Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...

“GLP-1 medications might help lower COPD exacerbation risk by reducing systemic inflammation, improving metabolic function, and possibly having direct effects on lung tissue,” she continued.

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

In the lungs of COPD patients, SPP1 is significantly upregulated. Experimentally, carbonaceous particles, which are related to environmental particle pollution, can cause the accumulation of SPP1+ ...

For additional context, check out the previously published stories in which the illustrations originally appeared in print and online, or see more of the artists’ work. (Illustration by Jun ...

Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio, USA Background The mechanisms underlying chronic obstructive pulmonary disease (COPD) remain unclear.